MorphoSys (MOR)
(Delayed Data from NSDQ)
$18.04 USD
-0.09 (-0.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.05 +0.01 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for MorphoSys AG Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 739 | 956 | 1,176 | 503 | 73 |
Receivables | 42 | 112 | 94 | 98 | 19 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 67 | 26 | 25 | 11 | 0 |
Other Current Assets | 33 | 54 | 47 | 766 | 248 |
Total Current Assets | 881 | 1,147 | 1,340 | 1,379 | 340 |
Net Property & Equipment | 4 | 6 | 8 | 7 | 5 |
Investments & Advances | 3 | 6 | 0 | 0 | 16 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 221 | 152 | 0 |
Intangibles | 1,284 | 1,309 | 1,389 | 81 | 50 |
Deposits & Other Assets | 9 | 9 | 16 | 226 | 96 |
Total Assets | 2,193 | 2,525 | 3,024 | 1,896 | 556 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 119 | 166 | 223 | 147 | 64 |
Current Portion Long-Term Debt | 2 | 2 | 1 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 1 | 1 | 0 | 0 |
Other Current Liabilities | 162 | 117 | 109 | 78 | 2 |
Total Current Liabilities | 286 | 293 | 337 | 229 | 69 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 7 | 7 | 26 | 6 | 0 |
Convertible Debt | 264 | 307 | 335 | 312 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,573 | 1,712 | 1,991 | 592 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,140 | 2,360 | 2,735 | 1,186 | 114 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 41 | 36 | 41 | 38 | 36 |
Capital Surplus | 1,015 | 878 | 986 | 856 | 704 |
Retained Earnings | -1,097 | -868 | -795 | -180 | -286 |
Other Equity | 96 | 122 | 62 | 3 | -1 |
Treasury Stock | 2 | 3 | 4 | 6 | 9 |
Total Shareholder's Equity | 53 | 166 | 290 | 710 | 442 |
Total Liabilities & Shareholder's Equity | 2,193 | 2,525 | 3,024 | 1,896 | 556 |
Total Common Equity | 53 | 166 | 290 | 710 | 442 |
Shares Outstanding | 150.60 | 136.90 | 136.90 | 131.50 | 126.70 |
Book Value Per Share | 0.35 | 1.21 | 2.12 | 5.40 | 3.49 |
Fiscal Year End for MorphoSys AG Unsponsored ADR falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 739 | 204 | 733 | 850 |
Receivables | NA | 42 | 64 | 94 | 84 |
Notes Receivable | NA | 0 | 1 | 0 | 0 |
Inventories | NA | 67 | 77 | 78 | 38 |
Other Current Assets | NA | 33 | 523 | 36 | 48 |
Total Current Assets | NA | 881 | 869 | 941 | 1,019 |
Net Property & Equipment | NA | 4 | 5 | 5 | 6 |
Investments & Advances | NA | 3 | 1 | 3 | 3 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1,284 | 1,359 | 1,330 | 1,309 |
Deposits & Other Assets | NA | 9 | 10 | 10 | 9 |
Total Assets | NA | 2,193 | 2,287 | 2,336 | 2,393 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 119 | 127 | 131 | 160 |
Current Portion Long-Term Debt | NA | 2 | 2 | 2 | 2 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 1 | 1 | 1 |
Other Current Liabilities | NA | 162 | 143 | 126 | 116 |
Total Current Liabilities | NA | 286 | 277 | 264 | 283 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 7 | 7 | 7 | 7 |
Convertible Debt | NA | 264 | 264 | 261 | 255 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1,773 | 1,730 | 1,704 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 2,140 | 2,360 | 2,302 | 2,289 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 41 | 37 | 37 | 37 |
Capital Surplus | NA | 1,015 | 918 | 918 | 896 |
Retained Earnings | NA | -1,097 | -1,155 | -1,027 | -932 |
Other Equity | NA | 96 | 129 | 108 | 106 |
Treasury Stock | NA | 2 | 2 | 3 | 3 |
Total Shareholder's Equity | NA | 53 | -73 | 35 | 104 |
Total Liabilities & Shareholder's Equity | NA | 2,193 | 2,287 | 2,336 | 2,393 |
Total Common Equity | 0 | 53 | -73 | 35 | 104 |
Shares Outstanding | 150.60 | 150.60 | NA | 136.90 | 136.90 |
Book Value Per Share | 0.00 | 0.35 | 0.00 | 0.25 | 0.76 |